Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. As the CTO of an AI-native email management startup, I've spent the past year building multi ...
Alzheimer's disease (AD) continues to be an unprecedented global challenge as populations age, severely impacting cognitive function and quality of life. While the recent approvals of monoclonal ...
What Is Loargys, and Why Does It Matter? Loargys is an enzyme-based medicine that has been granted accelerated approval by the FDA for managing high levels of the amino acid arginine (hyperargininemia ...
For most women, hormone therapy has long been a messy patchwork: an estrogen patch on the hip, a progesterone pill at night, a separate cream for dryness and—if libido crashes—a testosterone ...
Patients with systemic lupus erythematosus (SLE) who received belimumab monotherapy had remission rates, Lupus Low Disease Activity State (LLDAS) attainment, and flare rates comparable to those who ...
Treatment with Weekly TA-ERT Demonstrated Rapid and Durable Normalization of Cerebral Spinal Fluid Heparan Sulfate Non-Reducing End (CSF HS-NRE), a Surrogate Endpoint Reasonably Likely to Predict ...
Venglustat significantly improved neurological symptoms in patients with type 3 Gaucher disease compared with enzyme replacement therapy. Venglustat, an investigational glucosylceramide (GL-1) ...
The first new Sonos hardware product in over a year is the Sonos Amp Multi, a professional-grade multi-channel streaming amplifier designed specifically for large-scale residential audio installations ...
STOCKHOLM--(BUSINESS WIRE)--At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5' ...
Adenosine (ADO), as an endogenous purine nucleoside, can regulate almost all aspects of tissue function. However, its abnormal accumulation in the tumor microenvironment (TME) induces immune tolerance ...
Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ultra-rare disorder that causes progressive multisystem disease and neurologic ...
Stereotactic body radiotherapy (SBRT) alone achieves a 69.7% pooled 1- or 2-year systemic therapy-free survival rate across cancer types, with the highest rates seen in renal cell and prostate cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results